APA (7th ed.) Citation

A, B., S, R., J, A., LM, J., F, A., MC, R., . . . TB, A. (2024). The role of relative advantage for development of sequencing-based diagnostics for pediatric cancer in low- and middle-income countries. Cancer, 130(2), 173. https://doi.org/10.1002/cncr.35065

Chicago Style (17th ed.) Citation

A, Berger, et al. "The Role of Relative Advantage for Development of Sequencing-based Diagnostics for Pediatric Cancer in Low- and Middle-income Countries." Cancer 130, no. 2 (2024): 173. https://doi.org/10.1002/cncr.35065.

MLA (9th ed.) Citation

A, Berger, et al. "The Role of Relative Advantage for Development of Sequencing-based Diagnostics for Pediatric Cancer in Low- and Middle-income Countries." Cancer, vol. 130, no. 2, 2024, p. 173, https://doi.org/10.1002/cncr.35065.